Journal article
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial
Rates of varicella have decreased substantially in countries implementing routine varicella vaccination. Immunisation is possible with monovalent varicella vaccine or a combined measles-mumps-rubella-varicella vaccine (MMRV). The researchers assessed protection against varicella in naive children administered one dose of varicella vaccine or two doses of MMRV.
Authors
Languages
- English
Publication year
2014
Journal
The Lancet
Volume
9925
Type
Journal article
Categories
- Service delivery
Diseases
- Measles
- Mumps
- Rubella
- Varicella
Tags
- Coverage monitoring
